In the news release, BIOLASE, Inc. to Report Third Quarter 2018 Results on November 12, 2018, issued 01-Nov-2018 by BIOLASE, Inc. over PR Newswire, we are advised by the company that the date of the earnings release and conference call is November 13, 2018 rather than November 12, 2018 as originally issued inadvertently. The complete, corrected release follows:

BIOLASE, Inc. to Report Third Quarter 2018 Results on November 13, 2018

IRVINE, Calif., Nov. 1, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2018 financial and operating results on Tuesday, November 13, 2018 before the open of the U.S. financial markets. The Company will host a conference call and webcast on November 13, 2018 at 10:30 a.m. ET / 7:30 a.m. PT to discuss the results and corporate developments.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is 877-407-4019. For international participants outside the U.S./Canada, the dial-in number is 201-689-8337. For all callers, refer to the Conference ID 13683990. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients.  BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-third-quarter-2018-results-on-november-12-2018-300741916.html

SOURCE BIOLASE, Inc.